nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Thiotepa—sarcoma	0.245	0.458	CbGbCtD
Desvenlafaxine—CYP3A4—Mitoxantrone—sarcoma	0.105	0.197	CbGbCtD
Desvenlafaxine—CYP3A4—Vincristine—sarcoma	0.0726	0.136	CbGbCtD
Desvenlafaxine—CYP3A4—Etoposide—sarcoma	0.0665	0.124	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—sarcoma	0.0454	0.0848	CbGbCtD
Desvenlafaxine—Alopecia—Dactinomycin—sarcoma	0.00247	0.0053	CcSEcCtD
Desvenlafaxine—Mental disorder—Thiotepa—sarcoma	0.00246	0.0053	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Vincristine—sarcoma	0.00246	0.00529	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Vincristine—sarcoma	0.00245	0.00527	CcSEcCtD
Desvenlafaxine—Malnutrition—Thiotepa—sarcoma	0.00245	0.00526	CcSEcCtD
Desvenlafaxine—Urethral disorder—Vincristine—sarcoma	0.00244	0.00526	CcSEcCtD
Desvenlafaxine—Tension—Thiotepa—sarcoma	0.0024	0.00516	CcSEcCtD
Desvenlafaxine—Nervousness—Thiotepa—sarcoma	0.00238	0.00511	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Vincristine—sarcoma	0.00231	0.00498	CcSEcCtD
Desvenlafaxine—Bone disorder—Doxorubicin—sarcoma	0.00231	0.00497	CcSEcCtD
Desvenlafaxine—Vision blurred—Thiotepa—sarcoma	0.00231	0.00496	CcSEcCtD
Desvenlafaxine—Angiopathy—Vincristine—sarcoma	0.00226	0.00486	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Vincristine—sarcoma	0.00225	0.00483	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00223	0.0048	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Epirubicin—sarcoma	0.00223	0.00479	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Etoposide—sarcoma	0.00222	0.00477	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Etoposide—sarcoma	0.0022	0.00474	CcSEcCtD
Desvenlafaxine—Alopecia—Vincristine—sarcoma	0.0022	0.00474	CcSEcCtD
Desvenlafaxine—Mental disorder—Vincristine—sarcoma	0.00218	0.0047	CcSEcCtD
Desvenlafaxine—Chills—Mitoxantrone—sarcoma	0.00218	0.00468	CcSEcCtD
Desvenlafaxine—Alopecia—Mitoxantrone—sarcoma	0.00215	0.00461	CcSEcCtD
Desvenlafaxine—Convulsion—Thiotepa—sarcoma	0.00212	0.00456	CcSEcCtD
Desvenlafaxine—Hypertension—Thiotepa—sarcoma	0.00211	0.00454	CcSEcCtD
Desvenlafaxine—Anxiety—Thiotepa—sarcoma	0.00208	0.00446	CcSEcCtD
Desvenlafaxine—Dysgeusia—Mitoxantrone—sarcoma	0.00207	0.00445	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00207	0.00445	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Doxorubicin—sarcoma	0.00206	0.00443	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Etoposide—sarcoma	0.00199	0.00429	CcSEcCtD
Desvenlafaxine—Vision blurred—Mitoxantrone—sarcoma	0.00199	0.00428	CcSEcCtD
Desvenlafaxine—Urethral disorder—Etoposide—sarcoma	0.00198	0.00426	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Thiotepa—sarcoma	0.00196	0.00421	CcSEcCtD
Desvenlafaxine—Vertigo—Vincristine—sarcoma	0.00195	0.00419	CcSEcCtD
Desvenlafaxine—Tachycardia—Thiotepa—sarcoma	0.00195	0.00419	CcSEcCtD
Desvenlafaxine—Skin disorder—Thiotepa—sarcoma	0.00194	0.00417	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Etoposide—sarcoma	0.00191	0.00411	CcSEcCtD
Desvenlafaxine—Eye disorder—Etoposide—sarcoma	0.00189	0.00406	CcSEcCtD
Desvenlafaxine—Convulsion—Vincristine—sarcoma	0.00188	0.00404	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Etoposide—sarcoma	0.00187	0.00403	CcSEcCtD
Desvenlafaxine—Hypertension—Vincristine—sarcoma	0.00187	0.00403	CcSEcCtD
Desvenlafaxine—Angiopathy—Etoposide—sarcoma	0.00183	0.00394	CcSEcCtD
Desvenlafaxine—Convulsion—Mitoxantrone—sarcoma	0.00183	0.00394	CcSEcCtD
Desvenlafaxine—Hypertension—Mitoxantrone—sarcoma	0.00182	0.00392	CcSEcCtD
Desvenlafaxine—Immune system disorder—Etoposide—sarcoma	0.00182	0.00392	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Etoposide—sarcoma	0.00182	0.00391	CcSEcCtD
Desvenlafaxine—Chills—Etoposide—sarcoma	0.00181	0.0039	CcSEcCtD
Desvenlafaxine—Paraesthesia—Thiotepa—sarcoma	0.00179	0.00386	CcSEcCtD
Desvenlafaxine—Anxiety—Mitoxantrone—sarcoma	0.00179	0.00386	CcSEcCtD
Desvenlafaxine—Alopecia—Etoposide—sarcoma	0.00178	0.00384	CcSEcCtD
Desvenlafaxine—Somnolence—Thiotepa—sarcoma	0.00178	0.00382	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—sarcoma	0.00175	0.00376	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Vincristine—sarcoma	0.00174	0.00374	CcSEcCtD
Desvenlafaxine—Decreased appetite—Thiotepa—sarcoma	0.00174	0.00373	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—sarcoma	0.00173	0.00373	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00172	0.00371	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dactinomycin—sarcoma	0.00172	0.00371	CcSEcCtD
Desvenlafaxine—Fatigue—Thiotepa—sarcoma	0.00172	0.0037	CcSEcCtD
Desvenlafaxine—Dysgeusia—Etoposide—sarcoma	0.00172	0.0037	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Vincristine—sarcoma	0.00171	0.00368	CcSEcCtD
Desvenlafaxine—Fatigue—Dactinomycin—sarcoma	0.00171	0.00368	CcSEcCtD
Desvenlafaxine—Constipation—Thiotepa—sarcoma	0.00171	0.00367	CcSEcCtD
Desvenlafaxine—Shock—Mitoxantrone—sarcoma	0.0017	0.00365	CcSEcCtD
Desvenlafaxine—Tachycardia—Mitoxantrone—sarcoma	0.00168	0.00362	CcSEcCtD
Desvenlafaxine—Skin disorder—Mitoxantrone—sarcoma	0.00168	0.0036	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00167	0.00359	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—sarcoma	0.00164	0.00353	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00164	0.00352	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—sarcoma	0.00162	0.00348	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—sarcoma	0.0016	0.00345	CcSEcCtD
Desvenlafaxine—Insomnia—Vincristine—sarcoma	0.0016	0.00344	CcSEcCtD
Desvenlafaxine—Paraesthesia—Vincristine—sarcoma	0.00159	0.00342	CcSEcCtD
Desvenlafaxine—Vertigo—Etoposide—sarcoma	0.00158	0.0034	CcSEcCtD
Desvenlafaxine—Paraesthesia—Mitoxantrone—sarcoma	0.00155	0.00333	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Etoposide—sarcoma	0.00154	0.00332	CcSEcCtD
Desvenlafaxine—Decreased appetite—Vincristine—sarcoma	0.00154	0.00331	CcSEcCtD
Desvenlafaxine—Somnolence—Mitoxantrone—sarcoma	0.00153	0.0033	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Vincristine—sarcoma	0.00153	0.00329	CcSEcCtD
Desvenlafaxine—Fatigue—Vincristine—sarcoma	0.00153	0.00328	CcSEcCtD
Desvenlafaxine—Convulsion—Etoposide—sarcoma	0.00152	0.00328	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—sarcoma	0.00152	0.00327	CcSEcCtD
Desvenlafaxine—Hypertension—Etoposide—sarcoma	0.00152	0.00326	CcSEcCtD
Desvenlafaxine—Constipation—Vincristine—sarcoma	0.00151	0.00326	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00151	0.00326	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—sarcoma	0.00151	0.00325	CcSEcCtD
Desvenlafaxine—Decreased appetite—Mitoxantrone—sarcoma	0.0015	0.00322	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—sarcoma	0.00149	0.00321	CcSEcCtD
Desvenlafaxine—Fatigue—Mitoxantrone—sarcoma	0.00149	0.0032	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00149	0.0032	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—sarcoma	0.00148	0.00318	CcSEcCtD
Desvenlafaxine—Constipation—Mitoxantrone—sarcoma	0.00147	0.00317	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00147	0.00317	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Thiotepa—sarcoma	0.00147	0.00316	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Dactinomycin—sarcoma	0.00146	0.00314	CcSEcCtD
Desvenlafaxine—Asthenia—Thiotepa—sarcoma	0.00143	0.00308	CcSEcCtD
Desvenlafaxine—Asthenia—Dactinomycin—sarcoma	0.00142	0.00306	CcSEcCtD
Desvenlafaxine—Tachycardia—Etoposide—sarcoma	0.0014	0.00301	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—sarcoma	0.0014	0.00301	CcSEcCtD
Desvenlafaxine—Skin disorder—Etoposide—sarcoma	0.00139	0.003	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Etoposide—sarcoma	0.00139	0.00298	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00138	0.00297	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—sarcoma	0.00137	0.00294	CcSEcCtD
Desvenlafaxine—Diarrhoea—Thiotepa—sarcoma	0.00137	0.00294	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00136	0.00293	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dactinomycin—sarcoma	0.00136	0.00292	CcSEcCtD
Desvenlafaxine—Dizziness—Thiotepa—sarcoma	0.00132	0.00284	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Vincristine—sarcoma	0.0013	0.00281	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—sarcoma	0.00129	0.00278	CcSEcCtD
Desvenlafaxine—Paraesthesia—Etoposide—sarcoma	0.00129	0.00277	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—sarcoma	0.00129	0.00277	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—sarcoma	0.00128	0.00275	CcSEcCtD
Desvenlafaxine—Somnolence—Etoposide—sarcoma	0.00128	0.00274	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Mitoxantrone—sarcoma	0.00127	0.00273	CcSEcCtD
Desvenlafaxine—Asthenia—Vincristine—sarcoma	0.00127	0.00273	CcSEcCtD
Desvenlafaxine—Vomiting—Thiotepa—sarcoma	0.00127	0.00273	CcSEcCtD
Desvenlafaxine—Vomiting—Dactinomycin—sarcoma	0.00126	0.00271	CcSEcCtD
Desvenlafaxine—Rash—Thiotepa—sarcoma	0.00126	0.00271	CcSEcCtD
Desvenlafaxine—Dermatitis—Thiotepa—sarcoma	0.00126	0.00271	CcSEcCtD
Desvenlafaxine—Headache—Thiotepa—sarcoma	0.00125	0.00269	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00125	0.00269	CcSEcCtD
Desvenlafaxine—Rash—Dactinomycin—sarcoma	0.00125	0.00269	CcSEcCtD
Desvenlafaxine—Decreased appetite—Etoposide—sarcoma	0.00125	0.00268	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Etoposide—sarcoma	0.00124	0.00266	CcSEcCtD
Desvenlafaxine—Asthenia—Mitoxantrone—sarcoma	0.00124	0.00266	CcSEcCtD
Desvenlafaxine—Fatigue—Etoposide—sarcoma	0.00124	0.00266	CcSEcCtD
Desvenlafaxine—Constipation—Etoposide—sarcoma	0.00123	0.00264	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vincristine—sarcoma	0.00121	0.00261	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00119	0.00257	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—sarcoma	0.00119	0.00256	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—sarcoma	0.00119	0.00256	CcSEcCtD
Desvenlafaxine—Nausea—Thiotepa—sarcoma	0.00119	0.00255	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—sarcoma	0.00118	0.00255	CcSEcCtD
Desvenlafaxine—Diarrhoea—Mitoxantrone—sarcoma	0.00118	0.00254	CcSEcCtD
Desvenlafaxine—Nausea—Dactinomycin—sarcoma	0.00118	0.00253	CcSEcCtD
Desvenlafaxine—Dizziness—Vincristine—sarcoma	0.00117	0.00252	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00116	0.00249	CcSEcCtD
Desvenlafaxine—Vomiting—Vincristine—sarcoma	0.00113	0.00242	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—sarcoma	0.00112	0.0024	CcSEcCtD
Desvenlafaxine—Rash—Vincristine—sarcoma	0.00112	0.0024	CcSEcCtD
Desvenlafaxine—Dermatitis—Vincristine—sarcoma	0.00112	0.0024	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—sarcoma	0.00111	0.00239	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—sarcoma	0.00111	0.00239	CcSEcCtD
Desvenlafaxine—Headache—Vincristine—sarcoma	0.00111	0.00239	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—sarcoma	0.0011	0.00237	CcSEcCtD
Desvenlafaxine—Vomiting—Mitoxantrone—sarcoma	0.0011	0.00236	CcSEcCtD
Desvenlafaxine—Rash—Mitoxantrone—sarcoma	0.00109	0.00234	CcSEcCtD
Desvenlafaxine—Dermatitis—Mitoxantrone—sarcoma	0.00109	0.00234	CcSEcCtD
Desvenlafaxine—Headache—Mitoxantrone—sarcoma	0.00108	0.00232	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—sarcoma	0.00107	0.0023	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—sarcoma	0.00106	0.00227	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—sarcoma	0.00106	0.00227	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—sarcoma	0.00106	0.00227	CcSEcCtD
Desvenlafaxine—Nausea—Vincristine—sarcoma	0.00105	0.00226	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—sarcoma	0.00105	0.00226	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—sarcoma	0.00103	0.00222	CcSEcCtD
Desvenlafaxine—Asthenia—Etoposide—sarcoma	0.00103	0.00221	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—sarcoma	0.00103	0.00221	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—sarcoma	0.00103	0.00221	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—sarcoma	0.00103	0.00221	CcSEcCtD
Desvenlafaxine—Nausea—Mitoxantrone—sarcoma	0.00102	0.0022	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—sarcoma	0.00102	0.0022	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—sarcoma	0.00102	0.00219	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—sarcoma	0.00102	0.00218	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—sarcoma	0.001	0.00215	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—sarcoma	0.000992	0.00213	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—sarcoma	0.00099	0.00213	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—sarcoma	0.000985	0.00212	CcSEcCtD
Desvenlafaxine—Diarrhoea—Etoposide—sarcoma	0.000982	0.00211	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—sarcoma	0.000979	0.0021	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—sarcoma	0.000976	0.0021	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—sarcoma	0.000972	0.00209	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—sarcoma	0.000967	0.00208	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—sarcoma	0.000965	0.00208	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—sarcoma	0.000957	0.00206	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—sarcoma	0.00095	0.00204	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—sarcoma	0.000949	0.00204	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—sarcoma	0.000946	0.00203	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—sarcoma	0.000944	0.00203	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—sarcoma	0.00094	0.00202	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—sarcoma	0.000929	0.002	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—sarcoma	0.000925	0.00199	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—sarcoma	0.000918	0.00197	CcSEcCtD
Desvenlafaxine—Vomiting—Etoposide—sarcoma	0.000912	0.00196	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—sarcoma	0.000912	0.00196	CcSEcCtD
Desvenlafaxine—Rash—Etoposide—sarcoma	0.000905	0.00195	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—sarcoma	0.000904	0.00194	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—sarcoma	0.000899	0.00193	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—sarcoma	0.000895	0.00192	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—sarcoma	0.000893	0.00192	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—sarcoma	0.000885	0.0019	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—sarcoma	0.000885	0.0019	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—sarcoma	0.000884	0.0019	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—sarcoma	0.000871	0.00187	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—sarcoma	0.000866	0.00186	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—sarcoma	0.000859	0.00185	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—sarcoma	0.000854	0.00184	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—sarcoma	0.000852	0.00183	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—sarcoma	0.000851	0.00183	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—sarcoma	0.000836	0.0018	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000833	0.00179	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—sarcoma	0.00082	0.00176	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—sarcoma	0.000819	0.00176	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—sarcoma	0.000818	0.00176	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—sarcoma	0.000806	0.00173	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—sarcoma	0.000801	0.00172	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—sarcoma	0.000791	0.0017	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—sarcoma	0.00079	0.0017	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—sarcoma	0.000789	0.0017	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—sarcoma	0.000787	0.00169	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—sarcoma	0.000785	0.00169	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—sarcoma	0.000781	0.00168	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—sarcoma	0.000777	0.00167	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—sarcoma	0.000774	0.00166	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000771	0.00166	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—sarcoma	0.000759	0.00163	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—sarcoma	0.000732	0.00157	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—sarcoma	0.00073	0.00157	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—sarcoma	0.000727	0.00156	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—sarcoma	0.000726	0.00156	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—sarcoma	0.000723	0.00155	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—sarcoma	0.000722	0.00155	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—sarcoma	0.000719	0.00155	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—sarcoma	0.000715	0.00154	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—sarcoma	0.000699	0.0015	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000694	0.00149	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—sarcoma	0.000693	0.00149	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—sarcoma	0.000688	0.00148	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—sarcoma	0.000673	0.00145	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—sarcoma	0.000668	0.00144	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—sarcoma	0.000661	0.00142	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—sarcoma	0.000647	0.00139	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000642	0.00138	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—sarcoma	0.000642	0.00138	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—sarcoma	0.000636	0.00137	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—sarcoma	0.000592	0.00127	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—sarcoma	0.000577	0.00124	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—sarcoma	0.00055	0.00118	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—sarcoma	0.000548	0.00118	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—sarcoma	0.000534	0.00115	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—sarcoma	0.000532	0.00114	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—sarcoma	0.000511	0.0011	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—sarcoma	0.000509	0.00109	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—sarcoma	0.000507	0.00109	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—sarcoma	0.000507	0.00109	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—sarcoma	0.000504	0.00108	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—sarcoma	0.000492	0.00106	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—sarcoma	0.000478	0.00103	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—sarcoma	0.000473	0.00102	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—sarcoma	0.000469	0.00101	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—sarcoma	0.000469	0.00101	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—sarcoma	0.000466	0.001	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—sarcoma	0.000442	0.000951	CcSEcCtD
